All Reports Events Blogs Videos
Showing 93 results
  • PEAK Matrix®
    Oct. 29, 2025

    Enterprises are reimagining quality as a strategic engineering function rather than a downstream testing activity. As a result, demand for specialized Quality Engineering (QE) services is growing rapidly across industries. This analysis shows how the specialists…
  • Provider Compendium
    Aug. 22, 2025

    The increasing adoption of AI, generative AI, analytics, and industry-specific solutions across drug development, commercialization, and regulatory compliance is driving the rapid growth of digital services in the life sciences sector. Enterprises are turning to these…
  • Viewpoint
    Aug. 20, 2025

    AI’s rapid evolution is revolutionizing the life sciences sector. After significant generative AI-enabled advances, enterprises are now witnessing the rise of agentic AI – autonomous systems capable of independent decision-making and action execution. However, many life…
  • Provider Compendium
    Aug. 19, 2025

    Life sciences enterprises are reassessing how they engage with healthcare professionals and patients amid growing emphasis on hybrid commercial models and personalized experiences. This shift is prompting greater interest in next-generation Customer Engagement Platforms (CEPs) that…
  • PEAK Matrix®
    July 31, 2025

    Life sciences enterprises are expanding their use of Veeva Vault across regulated functions, including clinical operations, regulatory information management, quality systems, promotional content management, and CRM. As adoption moves beyond single modules to integrated, cross-Vault deployments,…
  • Webinar Deck
    July 31, 2025

    Life sciences commercial teams are facing tighter budgets, faster launch cycles, and growing pressure to prove ROI from every investment and engagement. In this high-stakes environment, a new breed of specialist providers is stepping up, reshaping…
  • Event
    July 29, 2025

    Life sciences commercial teams are facing tighter budgets, faster launch cycles, and growing pressure to prove ROI from every investment and engagement. In this high-stakes environment, a new breed of specialist providers is stepping up, reshaping…
  • LinkedIn Live
    July 09, 2025

    As life sciences companies continued to expand their use of Veeva across clinical, regulatory, quality, and commercial functions, the demand for specialized services intensified. From Vault implementation ️ and CRM migration to AI-enabled content and data…
  • PEAK Matrix®
    June 09, 2025

    The life sciences industry is undergoing rapid digital transformation, fueled by the need for greater agility, regulatory compliance, and patient-centric operations. Enterprise platforms such as SAP, Oracle, and Salesforce have evolved from back-end systems of record…
  • PEAK Matrix®
    June 02, 2025

    Life sciences enterprises are embracing digital technologies to navigate the growing complexities in drug development, commercialization, and regulatory compliance. As economic pressures and competitive dynamics intensify, organizations are turning to digital services to improve operational resilience…
  • May 20, 2025

    With Veeva and Salesforce parting ways and Salesforce pioneering agentic AI capabilities with Agentforce, enterprises were initially looking forward to what Veeva had in store for them.While enterprises continue to tackle the dilemma of migrating to…
  • Blog
    April 09, 2025

    Siemens, long known for its strength in industrial and manufacturing technology, has made a bold play in the scientific Research and Development (R&D) space with its $5.1 billion acquisition of Dotmatics. By pairing its strengths in…
  • PEAK Matrix®
    Nov. 07, 2024

    Life sciences companies must engage customers effectively to drive business success through differentiated experiences. Hybrid commercial models require seamless, personalized interactions across channels to serve healthcare providers and patients. Advanced Customer Engagement Platforms (CEPs) go beyond…
  • Blog
    Oct. 24, 2024

    Remember when we were all buzzing about the metaverse like it was going to redefine reality? Yeah, that was just two years ago!Fast forward to last year, and suddenly generative AI  (gen AI) has become the…
  • Market Insights™
    Sep. 26, 2024

  • Market Insights™
    Sep. 26, 2024

  • Market Insights™
    Sep. 11, 2024

  • Viewpoint
    Sep. 05, 2024

    Drug development is a complex, time-consuming, and expensive process. The average cost to develop a new drug has increased from US$1.3 million in 2013 to US$2.3 billion in 2022. This cost increase poses a significant challenge…
  • Market Insights™
    Aug. 30, 2024

  • Market Insights™
    Aug. 30, 2024

Items per page